Die perioperative Handhabung von Antikoagulantien in der elektiven Handchirurgie – eine Literaturübersicht

Zusammenfassung

Die vorliegende Arbeit beschreibt auf der Grundlage einer aktuellen Literaturrecherche mögliche Handlungspfade für die perioperative Handhabung von Antikoagulantien in der elektiven Handchirurgie.

Abstract

This review highlights pathways regarding the handling of anticoagulation in elective hand surgery based on current literature.

Schlüsselwörter

Antikoagulantien - elektive Handchirurgie

Key words

anticoagulants - elective hand surgery

• Literatur

• 1 Edmunds I, Avakian Z. Hand surgery on anticoagulated patients: a prospective study of 121 operations. Hand Surg 2010; 15: 109-113
• 2 Bogunovic L, Gelberman RH, Goldfarb CA et al. The impact of antiplatelet medication on hand and wrist surgery. J Hand Surg Am 2013; 38: 1063-1070
• 3 Jivan S, Southern S, Majumder S. Re: the effects of aspirin in patients undergoing carpal tunnel decompression. J Hand Surg Eur Vol 2008; 33: 813-814
• 4 Naito K, Lequint T, Zemirline A et al. Should we stop oral anticoagulants in the surgical treatment of carpal tunnel syndrome?. Hand 2012; 7: 267-270
• 5 Smit A, Hooper G. Elective hand surgery in patients taking warfarin. J Hand Surg Eur Vol 2004; 29: 204-205
• 6 Wallace DL, Latimer MD, Belcher HJ. Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg Eur Vol 2004; 29: 203-205
• 7 Lindsley RC. Perioperative management of systemic oral anticoagulants in patients having outpatient hand surgery. J Hand Surg Am 2008; 33: 1205-1207
• 8 Bogunovic L, Gelberman RH, Goldfarb CA et al. The Impact of Uninterrupted Warfarin on Hand and Wrist Surgery. J Hand Surg Am 2015; 40: 2133-2140
• 9 Schellong SM, Haas S, Siebenlist S. Überbrückung Pausieren und Wechsel von Antikoagulantien in der Unfallchirurgie. Unfallchirurg 2010; 113: 901-907
• 10 Spyropoulos AC, Douketis JD, Gerotziafas G et al. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. JTH 2012; 10: 692-694
• 11 Eisele R, Melzer N, Bramlage P. Perioperatives Gerinnungsmanagement bei oraler Antikoagulation. Chirurg 2014; 85: 513-519
• 12 European Heart Rhythm Association (EHRA), European Association for Cardio-Thoracic Surgery (EACTS). Camm AJ et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). EHJ 2010; 31: 2369-2429
• 13 Bridge Study Investigators. Bridging anticoagulation: is it needed when warfarin is interrupted around the time of a surgery or procedure?. Circulation 2012; 125: e496-e498
• 14 Bauersachs R, Schellong S, Haas S et al. Überbrückung der oralen Antikoagulation bei interventionellen Eingriffen. Dtsch Ärztebl Int 2007; 104: 1237-1244
• 15 Tiede A. Perioperatives hämostaseologisches Management. Chirurg 2007; 78: 69-79
• 16 Koscielny J, von Tempelhoff GF, Ziemer S et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10: 155-166
• 17 Tafur AJ, McBane R, Wysokinski WE et al. Predictors of major bleeding in peri-procedural anticoagulation management. JTH 10: 261-267
• 18 Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Int Med 2004; 164: 1319-1326
• 19 Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004; 147: 3-15
• 20 Spandorfer J. The management of anticoagulation before and after procedures. Med Clin North Am 2001; 85: 1109-1116
• 21 Jernberg T, Payne CD, Winters KJ et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. EHJ 2006; 27: 1166-1173
• 22 Smith MS, Muir H, Hall R. Perioperative management of drug therapy, clinical considerations. Drugs 1996; 51: 238-259
• 23 Vogel Kahmann I, Ruppen W, Lurati Buse G et al. Langzeitmedikation und perioperatives Management. Internist 2011; 52: 89-98
• 24 Biondi-Zoccai GG, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. EHJ 2006; 27: 2667-2674
• 25 Burger W, Chemnitius JM, Kneissl GD et al. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Int Med 2005; 257: 399-414
• 26 Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99: 316-328
• 27 Mangano DT. Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347: 1309-1317
• 28 Nuttall GA, Brown MJ, Stombaugh JW et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109: 588-595
• 29 Rabbitts JA, Nuttall GA, Brown MJ et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109: 596-604
• 30 Kozek-Langenecker SA. Lokoregionalanästhesie und Blutgerinnung. Behandlung mit Thrombozytenfunktionshemmern. Anaesthesist 2003; 52: 549-563
• 31 Lepper W, Kelm M. Perioperative Therapie mit Thrombozytenaggregationshemmern. Anaesthesist 2007; 56: 592-598
• 32 Abrahams MS, Aziz MF, Fu RF et al. Ultrasound guidance compared with electrical neurostimulation for peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials. Br J Anaesth 2009; 102: 408-417
• 33 Neuburger M, Buttner J. Komplikationen bei peripherer Regionalanästhesie. Anaesthesist 2011; 60: 1014-1026
• 34 Österreichische Gesellschaft für Anästhesie Reanimation und Intensivmedizin. Richtlinien perioperative Gerinnung 2010
• 35 Bristol-Myers Squibb. Fachinformation Eliquis^® 2012
• 36 Kreutz R. Pharmacodynamic and pharmacokinetic basics of rivaroxaban. Fundam Clin Pharmacol 2012; 26: 27-32
• 37 Bauersachs R, Gogarten W, Hach-Wunderle V et al. Perioperatives Management der Antikoagulation mit Rivaroxaban – Konsensus einer interdisziplinären Arbeitsgruppe. Klinikarzt 2012; 424-431
• 38 Bayer Pharma. Fachinformation Xarelto^® 2012
• 39 Liew A, Douketis J. Perioperative management of patients who are receiving a novel oral anticoagulant. Intern Emerg Med 2013; 8: 477-484
• 40 Spannagl M, Bauersachs R, Debus ES et al. Therapie mit Dabigatran. Periinterventionelles Management und Interpretation von Gerinnungstests. Haemostaseologie 2012; 32: 294-305
• 41 Douketis JD, Spyropoulos AC, Spencer FA et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis. Chest 2012; 141: e326S-e350S
• 42 Connolly G, Spyropoulos AC. Practical issues, limitations, and periprocedural management of the NOAC’s. J Thromb Thrombolysis 2013; 36: 212-222
• 43 Boehringer Ingelheim. Fachinformation Pradaxa^® 2014
• 44 Schellong SM, Haas S. Perioperative Thromboseprophylaxe – Neue orale Antikoagulantien und ihre Anwendung im Umfeld operativer Eingriffe. Anaesthesiol Intensivmed Notfallmed Schmerzther 2012; 47: 266-272
• 45 Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012; 120: 2954-2962
• 46 Schulman S, Crowther MA. How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood 2012; 119: 3016-3023
• 47 Vilchez JA, Gallego P, Lip GY. Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf 2014; 5: 8-20
• 48 AWMF. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Arbeitsgemeinschaften S3-Leitlinie zur Prophylaxe venöser Thromboembolien 2009
• 49 Siegal D, Yudin J, Kaatz S et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012; 126: 1630-1639
• 50 Gallego P, Apostolakis S, Lip GY. Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation. Circulation 2012; 126: 1573-1576
• 51 Sie P, Samama CM, Godier A et al. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Arch Cardio Dis 2011; 104: 669-676
• 52 Schlitt A, Jambor C, Spannagl M et al. Perioperativer Umgang mit Antikoagulanzien und Thrombozytenaggregationshemmern. Dtsch Ärztebl Int 2013; 110: 525-532
• 53 Lahtela H, Rubboli A, Schlitt A et al. Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Circ J 2012; 76: 1363-1368
• 54 Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. EHJ 2012; 33: 2719-2747
• 55 Healey JS, Eikelboom J, Douketis J et al. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation 2012; 126: 343-348
• 56 Wysokinski WE, McBane RD. Periprocedural bridging management of anticoagulation. Circulation 2012; 126: 486-490